Antimetabolites: all 7,305 studies that test it
Page 55 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Study of Tranilast Alone or in Combination With Allopurinol in Subjects With HyperuricemiaCompletedNCT01052987Phase 2
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced CancerCompletedNCT01050985Phase 1
- A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic CancerCompletedNCT01049880Phase 1
- CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantCompletedNCT01049854Phase 2
- RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOXCompletedNCT01049620Phase 1
- Study of Perifosine + Capecitabine for Colon Cancer PatientsCompletedNCT01048580Phase 1
- Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
- Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)CompletedNCT01048034Phase 2
- Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic SclerosisWithdrawnNCT01047072Phase 2
- Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)CompletedNCT01046864Phase 1
- Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for AdenocarcinomaWithdrawnNCT01045941Phase 2
- Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast CancerCompletedNCT01045304Phase 2
- Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal CancerCompletedNCT01043484Phase 2
- A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical ResectionCompletedNCT01043172Phase 2
- 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedNCT01041443Phase 1
- Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back PainCompletedNCT01040195Phase 3
- Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum TherapyCompletedNCT01039155Phase 1
- A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid LeukaemiaCompletedNCT01035502Phase 2
- Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal CarcinomaStatus unknownNCT01034683Phase 3
- Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01032057Phase 2
- Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01031368Phase 1
- Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)Status unknownNCT01031030Phase 3
- A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic CancerCompletedNCT01028495Phase 2
- IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)TerminatedNCT01027923Phase 1
- Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic CancerTerminatedNCT01025882Phase 1
- A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic CancerTerminatedNCT01025570Phase 1
- Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01024504Phase 2
- Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal CancerCompletedNCT01022541Phase 2
- Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionCompletedNCT01020734Phase 2
- Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk LeukemiaCompletedNCT01020539Phase 1
- A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic CancerCompletedNCT01019382Phase 2
- Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerWithdrawnNCT01017822Phase 1/2
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic ArthritisCompletedNCT01015547Phase 3
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- SC12267 (4SC-101) in Combination With Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT01010581Phase 2
- Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung CancerCompletedNCT01004601Not applicable
- Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IVCompletedNCT01003964Phase 2
- Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic PatientsTerminatedNCT01003678Phase 1
- Allopurinol Combination StudyCompletedNCT01001338Phase 2
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)CompletedNCT01001143Phase 1
- A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid TumorsCompletedNCT00999401Phase 1
- A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic AdenocarcinomaCompletedNCT00998322Phase 2
- Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)Status unknownNCT00997685Phase 2
- Allopurinol in Chronic Heart FailureCompletedNCT00997542Phase 4
- A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor MalignanciesCompletedNCT00996515Phase 1
- Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose CytarabineCompletedNCT00995332Phase 1/2
- Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCompletedNCT00995293Phase 3
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT00993343Phase 3
- Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric CancerStatus unknownNCT00992199Phase 2
- Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell LymphomaCompletedNCT00992134Phase 2
- Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)SuspendedNCT00991744Phase 3
- A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)CompletedNCT00991133Phase 1
- GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy SubjectsCompletedNCT00989703Phase 1
- Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-LymphomaStatus unknownNCT00989352Phase 2
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary CancerCompletedNCT00987766Phase 1
- Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post TransplantCompletedNCT00986804Phase 1
- Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerStatus unknownNCT00985556Phase 2
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic CancerCompletedNCT00983268Phase 1
- Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric CancerStatus unknownNCT00980603Phase 2
- A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric CarcinomaCompletedNCT00980382Phase 1/2
- The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal FailureCompletedNCT00978653Not applicable
- Effect of Hydroxyurea as Treatment for Primary Desmoid TumorsWithdrawnNCT00978146Phase 2
- Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXPCompletedNCT00976976Phase 2
- Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and CisplatinCompletedNCT00976768Phase 2
- Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)CompletedNCT00973609Phase 3
- Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00972881Phase 1/2
- Infusion of Expanded Cord Blood T CellsWithdrawnNCT00972101Phase 1
- Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaCompletedNCT00971763Phase 2
- Sickle Cell Disease Conditioning for Bone Marrow TransplantCompletedNCT00968162Phase 1
- Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal CancerStatus unknownNCT00967655Phase 2
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00967031Phase 2
- A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid ArthritisCompletedNCT00965653Phase 1
- Study of MBP-426 in Patients With Second Line Gastric, Gastroesophageal, or Esophageal AdenocarcinomaStatus unknownNCT00964080Phase 1/2
- Once Weekly D-cycloserine for SchizophreniaWithdrawnNCT00964041Phase 4
- Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryCompletedNCT00963729Phase 3
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00962312Phase 2
- Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric CancerStatus unknownNCT00961077Phase 2
- Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug MetabolismWithdrawnNCT00960544Phase 2
- Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer PatientsCompletedNCT00960349Phase 1
- Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic CancerCompletedNCT00960284Phase 2/3
- Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseStatus unknownNCT00959231Phase 2
- Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell LymphomaStatus unknownNCT00958854Phase 2
- Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal CancerTerminatedNCT00955240Phase 2
- Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal CancerWithdrawnNCT00954876Phase 2
- Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent LymphomaTerminatedNCT00954005Phase 1/2
- Predicting Response to Capecitabine in Women With Metastatic Breast CancerCompletedNCT00953537Not applicable
- A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric CancerCompletedNCT00952497Phase 2
- Methotrexate in Metastatic Colorectal Cancer With MSH2 DeficiencyTerminatedNCT00952016Phase 2
- Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal CancerTerminatedNCT00950820Phase 2
- Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard TherapyCompletedNCT00949949Phase 1
- Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus MesalazineCompletedNCT00946946Phase 3
- To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00946686Phase 1
- Trial of Simvastatin and Gemcitabine in Pancreatic Cancer PatientsCompletedNCT00944463Phase 2
- PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic LeukemiaTerminatedNCT00944008Phase 3
- Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic MalignanciesTerminatedNCT00943293Phase 1
- The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage CancerStatus unknownNCT00943137Phase 2
- Escalation Study to Determine Bioavailability of a Single Oral Dose of Decitabine in Patients With Myelodysplastic Syndrome (MDS)CompletedNCT00941109Phase 1
- Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic LeukemiaCompletedNCT00940524Phase 1
- TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung CancerCompletedNCT00940069Phase 2
- Safety and Tolerability Study of AZD7762 in Combination With GemcitabineTerminatedNCT00937664Phase 1